35 related articles for article (PubMed ID: 3501579)
1. Molecular targets for the protodynamic action of cis-urocanic acid in human bladder carcinoma cells.
Peuhu E; Kaunisto A; Laihia JK; Leino L; Eriksson JE
BMC Cancer; 2010 Oct; 10():521. PubMed ID: 20920317
[TBL] [Abstract][Full Text] [Related]
2. Cis-urocanic acid improves cell viability and suppresses inflammasome activation in human retinal pigment epithelial cells.
Korhonen E; Piippo N; Hytti M; Kaarniranta K; Kauppinen A
Biochem Pharmacol; 2023 Oct; 216():115790. PubMed ID: 37683842
[TBL] [Abstract][Full Text] [Related]
3. Epidermal trans-urocanic acid and the UV-A-induced photoaging of the skin.
Hanson KM; Simon JD
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10576-8. PubMed ID: 9724745
[TBL] [Abstract][Full Text] [Related]
4. Natural moisturising factor constituents in South African nursing students.
Young M; du Plessis JL; Kezic S; Jakasa I; Franken A
Contact Dermatitis; 2024 Apr; 90(4):378-384. PubMed ID: 38254239
[TBL] [Abstract][Full Text] [Related]
5. The effect of urocanic acid on graft rejection in an experimental model of orthotopic corneal transplantation in rabbits.
Filipec M; Letko E; Hasková Z; Jenícková D; Holler P; Jancárek A; Holán V
Graefes Arch Clin Exp Ophthalmol; 1998 Jan; 236(1):65-8. PubMed ID: 9457519
[TBL] [Abstract][Full Text] [Related]
6. Urocanic acid suppresses the activation of human neutrophils in vitro.
Kivistö K; Punnonen K; Toppari J; Leino L
Inflammation; 1996 Oct; 20(5):451-9. PubMed ID: 8894710
[TBL] [Abstract][Full Text] [Related]
7. Urocanic acid and cutaneous antigen presentation.
Lappin MB; Simon JC
J Photochem Photobiol B; 1998 Jul; 44(2):112-6. PubMed ID: 9757592
[TBL] [Abstract][Full Text] [Related]
8. Cis-urocanic acid stereospecifically modulates human monocyte IL-1 production and surface HLA-DR antigen expression, T-cell IL-2 production and CD4/CD8 ratio.
Räsänen L; Jansén CT; Hyöty H; Reunala T; Morrison H
Photodermatol; 1989 Dec; 6(6):287-92. PubMed ID: 2636983
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
Moodycliffe AM; Bucana CD; Kripke ML; Norval M; Ullrich SE
J Immunol; 1996 Oct; 157(7):2891-9. PubMed ID: 8816394
[TBL] [Abstract][Full Text] [Related]
10. cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha.
Kurimoto I; Streilein JW
J Immunol; 1992 May; 148(10):3072-8. PubMed ID: 1578133
[TBL] [Abstract][Full Text] [Related]
11. Urocanic acid enhances IL-10 production in activated CD4+ T cells.
Holán V; Kuffová L; Zajícová A; Krulová M; Filipec M; Holler P; Jancárek A
J Immunol; 1998 Oct; 161(7):3237-41. PubMed ID: 9759837
[TBL] [Abstract][Full Text] [Related]
12. [Urocanic acid and its role in the photoimmunomodulation process].
Malina L
Cas Lek Cesk; 2003 Aug; 142(8):470-3. PubMed ID: 14626561
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific inhibition of human epidermal cell interleukin-1 secretion and HLA-DR expression by cis-urocanic acid.
Räsänen L; Jansén CT; Reunala T; Morrison H
Photodermatol; 1987 Aug; 4(4):182-6. PubMed ID: 3501579
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
